Ping Chi, MD, PhD
Sarcoma Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Sarcomas of Soft Tissue and Bone
- Gastrointestinal Stromal Tumor (GIST)
- Malignant Peripheral Nerve Sheath Tumor (MPNST)
About Me
- Attending Physician
I am a physician-scientist and board-certified medical oncologist. At Memorial Sloan Kettering Cancer Center (MSK), I work closely with colleagues across areas, like surgery and radiation oncology, to care for people with soft tissue and bone sarcomas.
There are many different types of sarcomas. Personalized treatment is important because no two sarcomas are the same. The treatment plans that my colleagues, patients, and I create together are always focused on adjusting care to meet each patient’s needs and goals.
Read more
Just like no two sarcomas are the same, neither are two patients. We understand that every person we see has different needs and goals for treatment and we take the time to listen and really understand those needs and goals. This includes affordable access to medications. Patients are often worried about being able to afford the drugs that they need. I work with a clinical care team at MSK that does all that it can to get patients the medications they need at prices they can afford.
In addition to providing patient care, I run a laboratory in the Human Oncology and Pathogenesis Program (HOPP) at MSK focused on:
- The study of critical genetic and epigenetic “drivers”
- The development of novel biomarkers and therapeutics in sarcomas (in particular gastrointestinal stromal tumor and malignant peripheral nerve sheath tumor, and other sarcomas, using cell, tissue and mouse models).
My research centers on the pathogenesis (how a disease develops) of sarcomas, as well as the discovery of novel and effective treatments for sarcomas. I am currently involved in an effort with oncologists, pathologists, and surgeons aimed at analyzing tumor tissues to design clinical trials offering personalized therapy.
I am fluent in English and Mandarin.
A sarcoma medical oncologist is a cancer doctor who specializes in sarcoma. This includes soft tissue sarcomas (such as Ewing sarcoma and rhabdomyosarcoma) and benign (not cancer) growths that are like sarcoma.
My Specialties
- Sarcomas of Soft Tissue and Bone
- Gastrointestinal Stromal Tumor (GIST)
- Malignant Peripheral Nerve Sheath Tumor (MPNST)
Education
- MD, Weill Cornell Medical College
- PhD, The Rockefeller University
Residencies
- Internal Medicine - Brigham and Women's Hospital
Awards and Honors
- Election to the American Society for Clinical Investigation (ASCI, 2017)
- Boyer Award in Clinical Research (2017)
- Francis S. Collins Scholar Award, NTAP, Bloomberg Foundation (2017)
- Young Physician-Scientist Award, The American Society for Clinical Investigation (2014)
- NIH Director’s New Innovator Award, National Institutes of Health (2012)
- Sidney Kimmel Scholar Award (2012)
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
- The Rockefeller University
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Chi sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Clinical Trials
- Clinical Trials Investigated by Dr. Chi
- A Phase 1 Study Assessing Nivolumab Plus Ipilimumab Immunotherapy for Newly Diagnosed Malignant and Pre-malignant Peripheral Nerve Sheath Tumors
- A Phase 1/2 Study of DCC-3116 Plus Ripretinib for People with Advanced Gastrointestinal Stromal Tumor
- A Phase 3 Study of Ripretinib Versus Sunitinib in People With Advanced GIST Tumors With Certain Genetic Changes
- A Phase I Study of NB003 in People with Gastrointestinal Stromal Tumor or Another Solid Tumor
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ping Chi discloses the following relationships and financial interests:
-
Boxer Capital, LLC
Professional Services and Activities -
Deciphera
Professional Services and Activities
-
Ningbo NewBay Medical Technology Co., Ltd.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].